Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2021-08-12 $0.0216 $0.0349 $0.0215 $0.0310 387 565
2021-08-11 $0.0349 $0.0374 $0.0221 $0.0350 86 450
2021-08-10 $0.0290 $0.0350 $0.0250 $0.0290 34 927
2021-08-09 $0.0253 $0.0290 $0.0250 $0.0290 612 934
2021-08-06 $0.0249 $0.0290 $0.0249 $0.0290 612 934
2021-08-05 $0.0300 $0.0300 $0.0257 $0.0257 80 095
2021-08-04 $0.0256 $0.0300 $0.0256 $0.0299 31 663
2021-08-03 $0.0300 $0.0380 $0.0270 $0.0289 755 425
2021-08-02 $0.0389 $0.0389 $0.0250 $0.0300 175 467
2021-07-30 $0.0400 $0.0410 $0.0204 $0.0389 68 851
2021-07-29 $0.0400 $0.0400 $0.0300 $0.0389 68 851
2021-07-28 $0.0447 $0.0447 $0.0300 $0.0439 10 358
2021-07-27 $0.0498 $0.0498 $0.0266 $0.0266 1 243
2021-07-26 $0.0434 $0.0515 $0.0150 $0.0399 38 283
2021-07-23 $0.0445 $0.0600 $0.0444 $0.0444 100 165
2021-07-22 $0.0500 $0.0560 $0.0441 $0.0560 499
2021-07-21 $0.0435 $0.0560 $0.0435 $0.0560 18 612
2021-07-20 $0.0578 $0.0600 $0.0500 $0.0590 54 378
2021-07-19 $0.0502 $0.0590 $0.0500 $0.0590 54 378
2021-07-16 $0.0500 $0.0618 $0.0500 $0.0557 48 015
2021-07-15 $0.0510 $0.0618 $0.0501 $0.0600 34 453
2021-07-14 $0.0511 $0.0640 $0.0511 $0.0550 33 536
2021-07-13 $0.0511 $0.0643 $0.0511 $0.0643 14 048
2021-07-12 $0.0603 $0.0655 $0.0505 $0.0643 20 315
2021-07-09 $0.0655 $0.0655 $0.0515 $0.0655 6 508
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT